In Vitro Evidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSV tk Retroviral Gene Therapy

Human Gene Therapy

Volumn 4, Issue 6, 1993, Pages 725-731

  Bi, Wan Li ^a   Parysek, Linda M ^a   Warnick, Ronald ^a   Stambrook, Peter J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ARTICLE; AUTORADIOGRAPHY; CELL CONTACT; CELL DENSITY; CELL KILLING; CLONING VECTOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; DRUG SENSITIVITY; FIBROSARCOMA; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; ISOTOPE LABELING; MARKER GENE; NONHUMAN; RETROVIRUS; TUMOR CELL CULTURE;

BASE SEQUENCE; CELL COMMUNICATION; CELL COUNT; CELL DEATH; CELL DIVISION; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; GANCICLOVIR; GAP JUNCTIONS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMAN; MOLECULAR SEQUENCE DATA; SIMPLEXVIRUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

HERPES; HERPESVIRIDAE; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0027787053     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.1993.4.6-725     Document Type: Article

References (29)

1. ASHER, A.L., MULE, J.J., KASID, A., RESTIFO, N.P., SALO, J.C., REICHER, CM., JAFFE, G., FENDLY, B., KRIEGLER, M., and ROSENBERG. S.A. (1991). Murine tumor cells transduced with the gene of tumor necrosis factor against tumors. J. Immunol. 146, 3227-3234.
2. ASHTON, W.T., KARKAS, J.D., FIELD, A.K., and TOLMAN. R.L. (1982). Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxygIuanosine (2′NDG). Biochem. Biophys. Res. Commun. 108, 1716-1721.
3. CHENG. Y.C., GRILL. S.P., DUTSCHMAN, G.E., NAKAYAMA, K., and BASTOW, K.F. (1983). Metabolism of9-(1.3-dihydroxy-2-propoxymethyI)guanine. a new anti-herpes virus compound, in herpes simplex virus-infected cells. J. Biol. Chem. 258, 12460-12464.
4. COX, R.P., KRAUSS, M.R., BALIS, M.E., and DANCIS. J. (1972). Communication between normal and enzyme-deficient cells in tissue culture. Exp. Cell Res. 74, 251-268.
5. CULVER, K.W., RAM, Z., WALBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
6. DICKERMAN, L.H., and TISCHFIELD. J.A. (1978). Comparative effects of adenine analogs upon metabolic cooperation between hamster cells with different levels of adenine phosphoribosyltransference activity. Mutat. Res. 49, 83-94.
7. EZZEDDINE, Z.T., MARTUZA. R.L., PLATIKA. D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD. X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase. New Biol. 3, 608-614.
8. FEARON, E.R., PARDOLL. DM., ITAYA. T., GOLUBEK. P., LEVITSKI, H.L., SIMONS, J.W., KARASUYAMA. H., VOGELSTEIN, B., and FROST. P. (1990). Intedeukin-2 production by tumor cells bypasses T helper function in generation of an anti-tumor response. Cell 60, 397-403.
9. GANSBACHER, B., ZIER, K., DANNIELS, B., CRONIN, K., BANNERJI, R., and GILBOA. E. (1990a). Intedeukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med 1722, 1217-1224.
10. GANSBACHER, B., BANNERJI. R., DANNIELS. B., ZIER, K., CRONIN, K., and GILBOA. E. (1990b). Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting andtumor immunity. Cancer Res 50, 7820-7825.
11. GILULA, N.B., REEVES, O.R., and STEINBACH, A. (1972). Metabolic coupling, ionic coupling, and cell contacts. Nature 235, 262-265.
12. GORING, D.R., ROSSANT. J., CLAPOFF. S., BREITMAN, M.L., and TSUIL, C (1987). In situ detection of |3-gaIactosidase in lenses of transgenic mice with a 7-crystaIlin/Iac Z gene. Science 235, 456-458.
13. KARP, S.E., HWU, P., FARBER. A., RESTIFO, N.P., KRIEGLER. M., MULE, J.J., and ROSENBERG, S.A. (1992). In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retorvirally transduced murine tumor. J. Immunol. 149, 2076-2081.
14. KARP, S.E., FARBER. A., SALO. J.C., HWU, P., JAFFE, G., ASHER, A.L., SHILONI. E., RESTIFO, N.P., MULE, J.J., and ROSENBERG. S.A. (1993). Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor. J. Immunol. 150, 869-908.
15. KRIEGLER, M.P. (1990). Gene Transfer and Expression: A Laboratory Manual. (MacMillan Publisher Ltd. UK).
16. MARTIN, J.C., DVORAK, C.A., SMEE, D.F., MATTHEWS, T.R., and VERHEYDEN, J.P. (1983). 9-[(1,3-dihydroxy-2-propoxy) methyl]guanine: A new potent and selective antiherpes agent. J. Med. Chem. 26, 759-761.
17. MILLER, A.D., and BUTTIMORE. C (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 6, 2895-2902.
18. MOOLTEN, F.L., and WELLS. J.M. (1990). Curability of tumors bearing herpes simplex virus thymidine kinase gene. J. Natl. Cancer Inst. 82, 297-300.
19. MORGENSTERN, J.P., and LAND, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
20. MYHR, B.C., and DiPAOLO. J.A. (1975). Requirement for cell dispersion prior to selection of induced azaguanine-resistant colonies of Chinese hamster cells. Genetics 80, 157-169.
21. PLAUTZ, G., NABEL, E.G., and NABEL, G.J. (1991). Selective elimination of recombinant genes in vivo with a sucide retroviral vector. New Biol. 3, 709-715.
22. RAM. Z., CULVER. K.W., WALBRIDGE. R., BLAESE, R.M., and OLDFIELD. E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
23. RASHEED, S., NELSON-REES. W.A., TOTH, E.M., ARNSTEIN, P., and GARDNER, M.B. (1974). Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033.
24. ROSENBERG, S.A., AERBERSOLD. P., CORNETTA, K., KASID, A., MORGAN, R.A., MOEN, R., KARSON, E.M., LOTZE, M.T., YANG. J.C., TOPALIAN. S.L., MERINO, M.J., CULVER, K., MILLER, A.D., BLAESE, R.M., and ANDERSON, W.F. (1990). Gene transfer into humans—immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323, 570-578.
25. SUBAK-SHARPE. J.H., BURK, R.R., and PITTS. J.D. (1966). Metabolic cooperation by cell to cell transfer between genetically different mammalian cells. Heredity 21, 342-343.
26. SUBAK-SHARPE. J.H., BURK, R.R., and PITTS. J.D. (1969). Metabolic cooperation between biochemically marked mammalian cells in tissue culture. J. Cell Sci. 4, 353-367.
27. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy on malignant brain tumors: A rat glioma line bearing the Herpes Simplex virus Type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
28. TROJAN, J., JOHNSON, T.R., RUDIN, S.D., ILAN, J., and TYKOCINSKI, M.L. (1993). Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259, 94-97.
29. WEBER, J.S., and ROSENBERG. S.A. (1990). Effects of murine tumor class 1 major histocompatibility complex expression on antitumor activity of tumor infiltrating lymphocytes. J. Natl. Cancer Res. 82, 755-761.